159 related articles for article (PubMed ID: 34907177)
1. Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study.
Kang D; Yoon SE; Shin D; Lee J; Hong YS; Lee SK; Lee JE; Park YH; Ahn JS; Guallar E; Kim WS; Lee J; Kim SJ; Cho J
Blood Cancer J; 2021 Dec; 11(12):200. PubMed ID: 34907177
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Engels EA; Cho ER; Jee SH
Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
[TBL] [Abstract][Full Text] [Related]
3. Outdoor artificial light at night and risk of non-Hodgkin lymphoma among women in the California Teachers Study cohort.
Zhong C; Franklin M; Wiemels J; McKean-Cowdin R; Chung NT; Benbow J; Wang SS; Lacey JV; Longcore T
Cancer Epidemiol; 2020 Dec; 69():101811. PubMed ID: 33002844
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study.
Lee SJ; Suh CW; Lee SI; Kim WS; Lee WS; Kim HJ; Choi CW; Kim JS; Shin HJ;
Korean J Intern Med; 2014 May; 29(3):352-60. PubMed ID: 24851070
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort.
Teras LR; Patel AV; Hildebrand JS; Gapstur SM
Leuk Lymphoma; 2013 Apr; 54(4):720-5. PubMed ID: 22916741
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
8. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
9. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
[TBL] [Abstract][Full Text] [Related]
10. Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study.
Leo QJ; Ollberding NJ; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L; Maskarinec G
Cancer Causes Control; 2014 Nov; 25(11):1449-59. PubMed ID: 25070667
[TBL] [Abstract][Full Text] [Related]
11. A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma.
Bertrand KA; Giovannucci E; Zhang SM; Laden F; Rosner B; Birmann BM
Cancer Prev Res (Phila); 2013 Aug; 6(8):864-73. PubMed ID: 23803416
[TBL] [Abstract][Full Text] [Related]
12. Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma.
Luo J; Hendryx M; Rohan TE; Saquib N; Shadyab AH; Su L; Hosgood D; Schnatz PF; Qi L; Anderson GL
Int J Cancer; 2024 Apr; 154(8):1433-1442. PubMed ID: 38112671
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
14. No Association Observed between Coffee Intake and Risk of Non-Hodgkin Lymphoma among Postmenopausal Women.
Wang Z; Shadyab AH; Arthur R; Saquib N; Snetselaar LG; Johnson KC; Mu L; Chen Z; Luo J
J Acad Nutr Diet; 2022 Sep; 122(9):1725-1736. PubMed ID: 34737090
[TBL] [Abstract][Full Text] [Related]
15. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
17. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
[TBL] [Abstract][Full Text] [Related]
18. Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study.
Bertrand KA; Shingala J; Evens A; Birmann BM; Giovannucci E; Michaud DS
Int J Cancer; 2017 Mar; 140(5):1020-1026. PubMed ID: 27861844
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
